College of Food Science and Engineering, Jilin University, Changchun 130062, China.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove CZ500 05, Czech Republic.
Phytomedicine. 2021 Nov;92:153736. doi: 10.1016/j.phymed.2021.153736. Epub 2021 Sep 13.
Quercetin is a natural flavonoid, which widely exists in nature, such as tea, coffee, apples, and onions. Numerous studies have showed that quercetin has multiple biological activities such as anti-oxidation, anti-inflammatory, and anti-aging. Hence, quercetin has a significant therapeutic effect on cancers, obesity, diabetes, and other diseases. In the past decades, a large number of studies have shown that quercetin combined with other agents can significantly improve the overall therapeutic effect, compared to single use.
This work reviews the pharmacological activities of quercetin and its derivatives. In addition, this work also summarizes both in vivo and in vitro experimental evidence for the synergistic effect of quercetin against cancers and metabolic diseases.
An extensive systematic search for pharmacological activities and synergistic effect of quercetin was performed considering all the relevant literatures published until August 2021 through the databases including NCBI PubMed, Scopus, Web of Science, and Google Scholar. The relevant literatures were extracted from the databases with following keyword combinations: "pharmacological activities" OR "biological activities" OR "synergistic effect" OR "combined" OR "combination" AND "quercetin" as well as free-text words.
Quercetin and its derivatives possess multiple pharmacological activities including anti-cancer, anti-oxidant, anti-inflammatory, anti-cardiovascular, anti-aging, and neuroprotective activities. In addition, the synergistic effect of quercetin with small molecule agents against cancers and metabolic diseases has also been confirmed.
Quercetin cooperates with agents to improve the therapeutic effect by regulating signal molecules and blocking cell cycle. Synergistic therapy can reduce the dose of agents and avoid the possible toxic and side effects in the treatment process. Although quercetin treatment has some potential side effects, it is safe under the expected use conditions. Hence, quercetin has application value and potential strength as a clinical drug. Furthermore, quercetin, as the main effective therapeutic ingredient in traditional Chinese medicine, may effectively treat and prevent coronavirus disease 2019 (COVID-19).
槲皮素是一种天然类黄酮,广泛存在于自然界中,如茶、咖啡、苹果和洋葱。大量研究表明,槲皮素有多种生物活性,如抗氧化、抗炎和抗衰老。因此,槲皮素对癌症、肥胖、糖尿病等疾病具有显著的治疗作用。在过去的几十年里,大量研究表明,与单独使用相比,槲皮素与其他药物联合使用可以显著提高整体治疗效果。
本研究综述了槲皮素及其衍生物的药理学活性,并总结了槲皮素在体内和体外对癌症和代谢性疾病协同作用的实验证据。
通过 NCBI PubMed、Scopus、Web of Science 和 Google Scholar 等数据库,广泛系统地检索了截至 2021 年 8 月有关槲皮素药理学活性和协同作用的所有相关文献。使用以下关键词组合和自由文本词从数据库中提取相关文献:“药理学活性”或“生物学活性”或“协同作用”或“联合”或“组合”以及“槲皮素”。
槲皮素及其衍生物具有多种药理学活性,包括抗癌、抗氧化、抗炎、心血管保护、抗衰老和神经保护活性。此外,还证实了槲皮素与小分子药物联合治疗癌症和代谢性疾病的协同作用。
槲皮素通过调节信号分子和阻断细胞周期与药物协同作用,提高治疗效果。协同治疗可以减少药物剂量,避免治疗过程中可能出现的毒性和副作用。虽然槲皮素治疗有一些潜在的副作用,但在预期使用条件下是安全的。因此,槲皮素具有作为临床药物的应用价值和潜力。此外,槲皮素作为中药的主要有效治疗成分,可能有效治疗和预防 2019 年冠状病毒病(COVID-19)。